share_log

Summit Therapeutics Shares Are Trading Higher After the Company on Thursday Announced It Raised $235 Million in Net Proceeds.

Benzinga ·  Sep 14 02:07
Summit Therapeutics Shares Are Trading Higher After the Company on Thursday Announced It Raised $235 Million in Net Proceeds.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment